Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Integrated Genetics/Laboratory Corporation of America | RCV000586919 | SCV000697003 | uncertain significance | not provided | 2016-11-22 | criteria provided, single submitter | clinical testing | Variant summary: The CFTR c.4053G>C (p.Lys1351Asn) variant involves the alteration of a non-conserved nucleotide. 5/5 in silico tools predict a damaging outcome for this variant. This variant is absent in 121348 control chromosomes. The variant of interest has not, to our knowledge, been reported in affected individuals via publications and/or reputable databases/clinical diagnostic laboratories; nor evaluated for functional impact by in vivo/vitro studies. Because of the absence of clinical information and the lack of functional studies, the variant is classified as a variant of uncertain significance (VUS) until additional information becomes available. |
Counsyl | RCV000672552 | SCV000797665 | uncertain significance | Cystic fibrosis | 2018-02-06 | criteria provided, single submitter | clinical testing |